ClinicalTrials.Veeva

Menu

Frequency of Hepatobilliary Manifestations in Patients With Inflammatory Bowel Disease

A

Assiut University

Status

Unknown

Conditions

Hepatobilliary Manifestations in Inflammatory Bowel Disease Patients

Study type

Observational

Funder types

Other

Identifiers

NCT04613479
Inflammatory bowel disease

Details and patient eligibility

About

Hepatobilliary manifestations as extraintestinal manifestations of IBD are sometimes underdiagnosed which can impair patient prognosis

Full description

Non alcoholic fatty liver is aliver disease most commonly found in patient with IBD most commonly without intestinal activity.

On the other hand primary according cholangitis is the most common specific with IBD commonly with ulcerative colitis. and is commonly overlap with autoimmune hepatitis IBD therapy can also be a cause it can lead to hepatic toxicity and some drugs like ant TNF can cause hepatitis b virus activation.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:all patients diagnosed IBD crohns and ulcerative on conventional treatment and biological treatment -

Exclusion Criteria:no

Trial contacts and locations

0

Loading...

Central trial contact

Hussein Elamin

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems